CYP3A4, cytochrome P450 family 3 subfamily A member 4, 1576
N. diseases: 291; N. variants: 17
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 7 | 99768693 | intron variant | G/A | snv | 3.2E-02 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
1.000 | 7 | 99771177 | intron variant | -/CT | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 7 | 99771177 | intron variant | -/CT | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 7 | 99771177 | intron variant | -/CT | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 7 | 99771177 | intron variant | -/CT | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 7 | 99771177 | intron variant | -/CT | delins |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
7 | 99777087 | intron variant | T/C | snv | 8.8E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.882 | 0.120 | 7 | 99763843 | intron variant | C/T | snv | 0.22 | 0.32 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||
|
0.882 | 0.120 | 7 | 99763843 | intron variant | C/T | snv | 0.22 | 0.32 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||||
|
7 | 99768470 | missense variant | G/C | snv | 7.6E-05 | 5.6E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
7 | 99768470 | missense variant | G/C | snv | 7.6E-05 | 5.6E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
7 | 99766440 | stop gained | G/A;T | snv | 6.4E-05 | 7.7E-05 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
7 | 99766440 | stop gained | G/A;T | snv | 6.4E-05 | 7.7E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
7 | 99766440 | stop gained | G/A;T | snv | 6.4E-05 | 7.7E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.120 | 7 | 99778046 | missense variant | T/C;G | snv | 7.6E-05 | 6.3E-05 |
|
0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.882 | 0.120 | 7 | 99778046 | missense variant | T/C;G | snv | 7.6E-05 | 6.3E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.882 | 0.120 | 7 | 99778046 | missense variant | T/C;G | snv | 7.6E-05 | 6.3E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.882 | 0.120 | 7 | 99763843 | intron variant | C/T | snv | 0.22 | 0.32 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.882 | 0.120 | 7 | 99763843 | intron variant | C/T | snv | 0.22 | 0.32 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.882 | 0.120 | 7 | 99763843 | intron variant | C/T | snv | 0.22 | 0.32 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.040 | 7 | 99768096 | intron variant | A/G | snv | 0.31 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2010 | 2010 |